SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...

ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ ...

Topical medications remain the cornerstone ... of preservatives used in the medications and the total number of all eye drops used by the patient throughout the day. Owing to the potential adverse ...

Robert W. Baird analyst Colleen M. Kusy maintained a Buy rating on Oculis Holding (OCS – Research Report) on November 7 and set a price ...

About Eyenovia, Inc. Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic ... versus ...

Advanced Phase 3 CHAPERONE study of MicroPine as a treatment of pediatric progressive myopia with preparations for interim analysis this ...

Among the 422 eyes examined in the study, 94 had received no previous atropine treatment, while 328 had received between two ...

Harrow Inc. experienced a brief 20% stock drop in October but quickly recovered, showing resilience despite recent revenue channel underperformance. Read more here.

Third, the eye is a small organ that offers easy accessibility for application of a nano-treatment, either as a topical drop or as an injection into the anterior or posterior chamber of the eye.

A drug-eluting contact lens that uses 3D printing technology can improve IOP and treatment compliance for patients with glaucoma.

In two days, the stock price of Akums Drugs has declined 19% to Rs 645.30 and fallen below its issue price of Rs 679 per ...